Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. (Q37959053)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

François Mach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Cardiovascular Therapy

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1519-1525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

The phenothiazinium chromophore and the evolution of antimalarial drugs

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

"Lest we forget you--methylene blue...".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Methylene blue and vasoplegia: who, when, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Vasoplegic syndrome--the role of methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Pharmacokinetics and organ distribution of intravenous and oral methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Anaphylaxis reaction of a breast cancer patient to methylene blue during breast surgery with sentinel node mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Anaphylactic reaction after methylene blue-treated plasma transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Anaphylactic shock to fresh‐frozen plasma inactivated with methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Cardiac Arrest after Patent Blue V Injection for Sentinel Lymph Node Biopsy in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Are there teratogenic risks associated with antidotes used in the acute management of poisoned pregnant women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Endotoxemia in coronary artery bypass surgery: A comparison of the off-pump technique and conventional cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Nitric oxide signalling in the regulation of cardiovascular and platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

NO., CO and .OH. Endogenous soluble guanylyl cyclase-activating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Vasoplegia During Cardiac Surgery: Current Concepts and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Methylene blue inhibits the increase of inducible nitric oxide synthase activity induced by stress and lipopolysaccharide in the medial basal hypothalamus of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Con: Methylene Blue Should Not Be Used Routinely for Vasoplegia Perioperatively

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Pro: Methylene Blue as a Rescue Therapy for Vasoplegia After Cardiac Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Use of methylene blue in the treatment of vasoplegic syndrome of post-operative heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.160

21 January 2018

Identifiers

DOI

10.1586/ERC.11.160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json

release_f5sj4ml4nre6nkigkv4p7gdyj4

17 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f5sj4ml4nre6nkigkv4p7gdyj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22103871%20AND%20SRC:MED&resulttype=core&format=json